No responses to oral etoposide in 15 patients with recurrent brain tumors.
Korones
D N
DN
Children's Hospital at Strong and The University of Rochester Cancer Center, NY 14642, USA. david_korones@urmc.rochester.edu
Fisher
P G
PG
Cohen
K J
KJ
Dubowy
R L
RL
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D002648:Child; D002675:Child, Preschool; D005047:Etoposide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
D000972:Antineoplastic Agents, Phytogenic; D005047:Etoposide